Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC Meeting Abstract
| Authors: | Strickler, J. H.; Cercek, A.; Siena, S.; Andre, T.; Ng, K.; Van Cutsem, E.; Wu, C.; Paulson, A. S.; Hubbard, J.; Coveler, A.; Fountzilas, C.; Kardosh, A.; Kasi, P. M.; Lenz, H. J.; Ciombor, K. K.; Fernandez, M. E. E.; Bajor, D. L.; Stecher, M.; Feng, W.; Bekaii-Saab, T. |
| Abstract Title: | Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1394 |
| Language: | English |
| ACCESSION: | WOS:000866211602433 |
| DOI: | 10.1016/j.annonc.2022.08.023 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA27 -- Source: Wos |
